What does this study add
Using dynamic mass redistribution technology, we have developed a novel cell-based assay that can be used to determine and confirm the pharmacological properties of new molecules identified through more traditional second messenger focused screening methodologies for Mas-related gene D receptor.
This new method provides a bridge to more translatable, cell or phenotypic assays as it aggregates the total cellular response to compound treatment.